| 121 |
LEDRIT |
LOPERAMIDE HYDROCHLORIDE BP 2 MG |
HARD GELATIN CAPSULE |
ALU-PVC BLISTER |
FOR SYMPTOMATIC TREATMENT OF ACUTE DIARRHEA |
NULL |
ASA LAO SOLE COMPANY LIMITED |
PROTECH BIOSYSTEMS PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
05 I 5917/25 |
19-MAY-2025 |
18-MAY-2030 |
View |
| 122 |
METROGUARD 500 |
METRONIDAZOLE USP 500 MG |
FILM COATED TABLET |
ALU-PVC BLISTER |
PREVENTION OF POST OPERATIVE INFECTION DUE TO ANEROBIC BACTERIA, PARTICULARY SPECIES OF BACTEROIDS AND ANAEROBIC STREPTOCOCCI. TREATMENT OF SEPTICAEMIA, BACTERAEMIA, PERITONITIS, BRAIN ABSCESS, NECROTISING PNEUMONIA, OSTEOMYELITIS, PUERPERAL SEPSIS, PELVIC ABCESS, PELVIC CELLULITIS AND POST OPERATIVE WOUND INFECTION. UROGENITAL TRICHOMONIASIS IN THE FEMALE AND IN MAN |
NULL |
ASA LAO SOLE COMPANY LIMITED |
PROTECH BIOSYSTEMS PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
05 I 5918/25 |
19-MAY-2025 |
18-MAY-2030 |
View |
| 123 |
METRONIDAZOLE PROTECH |
METRONIDAZOLE USP 500 MG/100 ML |
SOLUTION FOR INJECTION |
BOTTLE |
THE PROPHYLAXIS OF POSTOPERATIVE INFECTION DUE TO SENSITIVE ANAEROBIC STREPTOCOCCI, DURING ABDOMINAL, GYNAECOLOGICAL GASTROINTESTINAL OR COLORECTAL SURGERY WHICH CARRIES A HIGH RISK OF CONCURRENCE OF THIS TYPE OF INFECTION. TREATMENT OF SEVERE INTRAABDOMINAL AND GYNAECOLOGICAL INFECTION |
NULL |
ASA LAO SOLE COMPANY LIMITED |
PROTECH BIOSYSTEMS PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
05 I 5919/25 |
19-MAY-2025 |
18-MAY-2030 |
View |
| 124 |
MXIDINE |
CHLORHEXIDINE GLUCONATE SOLUTION BP DILUTED TO CHLORHEXIDINE GLUCONATE 0.2% W/V |
SOLUTION |
BOTTLE |
DECREASING THE AMOUNT OF BACTERIA IN THE MOUTH, HELPING TO REDUCE SWELLING AND REDNESS OF THE GUMS AND BLEEDING WHEN YOU BRUSH |
NULL |
ASA LAO SOLE COMPANY LIMITED |
MERIT ORGANICS LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5866/25 |
31-JAN-2025 |
30-JAN-2030 |
View |
| 125 |
PLATOKAM 75 |
ASPIRIN BP 75 MG |
ENTERIC COATED TABLET |
ALU-ALU BLISTER |
FOR THE SECONDARY PREVENTION OF THROMBOTIC CEREBROVASCULAR OR CARDIOVASCULAR DISEASE AND FOLLOWING BY-PASS SURGERY |
NULL |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5867/25 |
31-JAN-2025 |
30-JAN-2030 |
View |
| 126 |
PROPANTO 40 |
PANTOPRAZOLE SODIUM USP EQ.TO PANTOPRAZOLE 40 MG |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
REFLUX OESOPHAGITIS, GASTRIC AND DUODENAL ULCER, ZOLLINGER-ELISSON SYNDROME AND OTHER PATHOLOGICAL HYPERSECRETORY CONDITION |
NULL |
ASA LAO SOLE COMPANY LIMITED |
PROTECH BIOSYSTEMS PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
05 I 5920/25 |
19-MAY-2025 |
18-MAY-2030 |
View |
| 127 |
ROSUKAM 10 |
ROSUVASTATIN CALCIUM BP EQ.TO ROSUVASTATIN 10 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
TREATMENT OF HYPERCHOLESTEROLAEMIA, PREVENTION OF CARDIOVASCULAR EVENT |
NULL |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
09 I 5800/24 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 128 |
ROSUKAM 20 |
ROSUVASTATIN CALCIUM BP EQ.TO ROSUVASTATIN 20 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
TREATMENT OF HYPERCHOLESTEROLAEMIA, PREVENTION OF CARDIOVASCULAR EVENT |
NULL |
ASA LAO SOLE COMPANY LIMITED |
IMPULSE PHARMA PVT. LTD |
INDIA |
CERTIFICATE RELEASED |
09 I 5799/24 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 129 |
SIRMOX-250 CAPSULES |
AMOXICILLIN TRIHYDRATE USP EQ.TO AMOXICILLIN 250 MG |
CAPSULE |
ALU-PVC BLISTER |
ACUTE BACTERIAL SINUSITIS, ACUTE OTITIS MEDIA, ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, COMMUNITY ACQUIRED PNEUMONIA, CYSTITIS, PYELONEPHRITIS, SKIN AND SOFT TISSUE INFECTION, BONE AND JOINT INFECTION. |
NULL |
ASA LAO SOLE COMPANY LIMITED |
KRUX PHARMA PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
04 I 5460/23 |
11-APR-2023 |
10-APR-2026 |
View |
| 130 |
SIRMOX-250 ORAL SUSPENSION |
AMOXICILLIN TRIHYDRATE USP EQ.TO AMOXICILLIN 250 MG/5 ML |
SUSPENSION |
BOTTLE |
ACUTE BACTERIAL SINUSITIS, ACUTE OTITIS MEDIA, ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, COMMUNITY ACQUIRED PNEUMONIA, CYSTITIS, PYELONEPHRITIS, SKIN AND SOFT TISSUE INFECTION, BONE AND JOINT INFECTION. |
NULL |
ASA LAO SOLE COMPANY LIMITED |
KRUX PHARMA PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
04 I 5461/23 |
11-APR-2023 |
10-APR-2026 |
View |
